Insider filing · TARS
Jeffrey S Farrow
See Remarks
profile →
Tarsus Pharmaceuticals, Inc.
TARS · Healthcare · 35 filings in 24 months
ticker →
Jeffrey S Farrow sold $550K of Tarsus Pharmaceuticals (TARS)
Executed Jun 17 2025, disclosed Jun 18 2025, 1 day later.
Value, as filed
$550K
13,608 sh × $40.42
Executed
Jun 17 2025
the trade date, as filed
Disclosed
Jun 18 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JFJeffrey S Farrow (See Remarks) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Tarsus Pharmaceuticals, Inc. (TARS). The largest single filing was $877K of TARS (14,396 sh × $60.95, as filed), executed Jun 16.
The name
TARSHealthcare · Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Jeffrey S Farrow in TARS
TARSSALE
Tarsus Pharmaceuticals, Inc.
$877K14,396 sh × $60.95
Exec Jun 16
Filed Jun 17 · 5:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. $440K
6,430 sh across 3 lots
Exec Mar 17
Filed Mar 19 · 5:30 PM ET